- Home
- CAN vs SLRN Comparison
CAN vs SLRN Comparison
Compare CAN & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAN
- SLRN
- Stock Information
- Founded
- CAN 2013
- SLRN 2020
- Country
- CAN Singapore
- SLRN United States
- Employees
- CAN N/A
- SLRN N/A
- Industry
- CAN Semiconductors
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- CAN Technology
- SLRN Health Care
- Exchange
- CAN Nasdaq
- SLRN Nasdaq
- Market Cap
- CAN 425.9M
- SLRN 485.6M
- IPO Year
- CAN 2019
- SLRN 2023
- Fundamental
- Price
- CAN $2.14
- SLRN $4.30
- Analyst Decision
- CAN Strong Buy
- SLRN Hold
- Analyst Count
- CAN 4
- SLRN 5
- Target Price
- CAN $3.38
- SLRN $11.40
- AVG Volume (30 Days)
- CAN 20.8M
- SLRN 484.8K
- Earning Date
- CAN 11-20-2024
- SLRN 11-13-2024
- Dividend Yield
- CAN N/A
- SLRN N/A
- EPS Growth
- CAN N/A
- SLRN N/A
- EPS
- CAN N/A
- SLRN N/A
- Revenue
- CAN $229,630,000.00
- SLRN N/A
- Revenue This Year
- CAN $23.60
- SLRN N/A
- Revenue Next Year
- CAN $60.15
- SLRN N/A
- P/E Ratio
- CAN N/A
- SLRN N/A
- Revenue Growth
- CAN N/A
- SLRN N/A
- 52 Week Low
- CAN $0.72
- SLRN $3.36
- 52 Week High
- CAN $3.50
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- CAN 66.06
- SLRN 32.86
- Support Level
- CAN $1.73
- SLRN $4.24
- Resistance Level
- CAN $2.26
- SLRN $4.87
- Average True Range (ATR)
- CAN 0.27
- SLRN 0.42
- MACD
- CAN 0.03
- SLRN -0.07
- Stochastic Oscillator
- CAN 85.54
- SLRN 4.06
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.